Alzheimer´'s disease
Abstract
Alzheimer's disease (AD) is a progressive disease that is reflected in markers through evaluation modalities, including neuroimaging, cognitive tests and adaptive function evaluation. The objective of this study is to know the symptoms, treatment and possible causes of Alzheimer's disease and the effects on the social environment of people who suffer. In conclusion we think that it is completely true to consider Alzheimer's disease as "the most dangerous, incurable and difficult to face senile dementia in a family environment", since the disease is associated with other pathological disorders that can lead to death and that the knowledge we have about her is still a bit uncertain.
Downloads
References
Torbio, L. (2016) 800 mil mexicanos padecen Alzheimer. Excelsior. México. Recuperado de: http://www.excelsior.com.mx/nacional/2016/09/22/1118330
Álvarez Sanchez, M (2008) Fisiopatología de la enfermedad de Alzheimer. Revista Mexicana de Neurociencia, 9(6): 196-201.
Cabrera, M. (2014) Patogenia y tratamientos actuales de la enfermedad de Alzheimer. Revista Cubana de Farmacia, 48(2):508-518
Campellone, J (2018) Mal de Alzheimer. Medlineplus. Recuperado de:https://medlineplus.gov/spanish/ency/article/000760.htm
Custodio, N. (2015) Enfermedad de Alzheimer. Conociendo la enfermedad que llegó para quedarse. (editorial no especificada) Lima, Perú
Ford, A. (2014) Neuropsychiatric aspects of dementia, Maturitas, 79(8): 209-215.
Crespo, M. y Salgado, A. (2010). Demencia y residencia: la voz de los profesionales. News Tercera Edad, 8(10): 8-9.
Wischik, C et al (2014) Tau-aggregation inhibitor therapy for Alzheimer’s disease. Biochemical pharmacology, 88(1): 529 539.
Castellani, L et al. (2010) Alzheimer Disease,Alzheimer’s asociation. 56(6): 484-546.
Toledano, A. La enfermedad de Alzheimer: la demencia que pone en jaque a la sociedad del siglo XXI. ACTA. Revisado 29 de octubre del 2019 en:
